Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House passes early cancer detection bill

This article was originally published in The Gray Sheet

Executive Summary

On March 27, House passes bill (HR 1132) authorizing $1.25 billion for breast and cervical cancer screening programs between 2008-2012. Introduced by Reps. Tammy Baldwin, D-Wisc., and Sue Myrick, R-N.C., the measure reauthorizes the National Breast and Cervical Cancer Early Detection Program. The bill also changes the target date for achieving reductions in the rate of mortality from breast and cervical cancer from 2000 to 2020. Senate companion legislation (S 624), introduced by Sens. Barbara Mikulski, D-Md., and Kay Hutchison, R-Texas, was approved by the Senate Health, Education, Labor & Pensions Committee on March 15...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel